flumazenil has been researched along with Basal Ganglia Cerebrovascular Disease in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Basal Ganglia Cerebrovascular Disease: A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihara, M | 1 |
| Tomimoto, H | 1 |
| Ishizu, K | 1 |
| Yoshida, H | 1 |
| Sawamoto, N | 1 |
| Hashikawa, K | 1 |
| Fukuyama, H | 1 |
1 other study available for flumazenil and Basal Ganglia Cerebrovascular Disease
| Article | Year |
|---|---|
Association of vascular parkinsonism with impaired neuronal integrity in the striatum.
Topics: Aged; Aged, 80 and over; Basal Ganglia; Basal Ganglia Cerebrovascular Disease; Carbon Radioisotopes; | 2007 |